GOP Wary Of Attys' Influence On FDA Generics Labeling Rule
Three Republican members of the House Committee on Oversight and Government Reform have called on the U.S. Food and Drug Administration to answer questions about a plan to revamp safety warning...To view the full article, register now.
Already a subscriber? Click here to view full article